Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.

Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer. is a phase 2, interventional study registered as NCT02919644 by Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS, with a registry enrolment figure of 19 participants, started 2016-12-02 and due to reach its primary completion in 2026-12. Interventions recorded: autologous dendritic cells loaded with autologous tumour homogenate; IL2. Conditions listed: Stage IV Colorectal Cancer; Curative Resection. Primary outcome: Incidence of Treatment-Emergent Adverse Events; immunological efficacy. Colorectal eligibility wording from the registry: "Patients must have histologically confirmed stage IV colorectal cancer surgically treated with radical intent". Sites: Italy. No results are recorded here; the registry entry is the source.